These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 9423141)

  • 1. Oral formulations of adefovir dipivoxil: in vitro dissolution and in vivo bioavailability in dogs.
    Cundy KC; Sue IL; Visor GC; Marshburn J; Nakamura C; Lee WA; Shaw JP
    J Pharm Sci; 1997 Dec; 86(12):1334-8. PubMed ID: 9423141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic properties of single-dose lamivudine/adefovir dipivoxil fixed-dose combination in healthy Chinese male volunteers.
    Fok BS; Gardner S; Piscitelli S; Chen S; Chu TT; Chan JC; Tomlinson B
    Clin Ther; 2013 Jan; 35(1):68-76. PubMed ID: 23274144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of adefovir dipivoxil tablets in healthy Chinese volunteers.
    Huang J; Zhang Y; Huang X; Li L; Li Y; Wang K; Yang J; He Y; Lv Y; Zheng Q
    Int J Clin Pharmacol Ther; 2014 Jan; 52(1):8-14. PubMed ID: 24219967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral efficacy and pharmacokinetics of oral adefovir dipivoxil in chronically woodchuck hepatitis virus-infected woodchucks.
    Cullen JM; Li DH; Brown C; Eisenberg EJ; Cundy KC; Wolfe J; Toole J; Gibbs C
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2740-5. PubMed ID: 11557463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of basolateral efflux transporter MRP4 in the intestinal absorption of the antiviral drug adefovir dipivoxil.
    Ming X; Thakker DR
    Biochem Pharmacol; 2010 Feb; 79(3):455-62. PubMed ID: 19735648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cinnarizine food-effects in beagle dogs can be avoided by administration in a Self Nano Emulsifying Drug Delivery System (SNEDDS).
    Christiansen ML; Holm R; Kristensen J; Kreilgaard M; Jacobsen J; Abrahamsson B; Müllertz A
    Eur J Pharm Sci; 2014 Jun; 57():164-72. PubMed ID: 24239996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid lipid nanoparticles and nanosuspension of adefovir dipivoxil for bioavailability improvement: formulation, characterization, pharmacokinetic and biodistribution studies.
    Dodiya S; Chavhan S; Korde A; Sawant KK
    Drug Dev Ind Pharm; 2013 May; 39(5):733-43. PubMed ID: 22690834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 1α,25-Dihydroxyvitamin D3 on Intestinal Absorption and Disposition of Adefovir Dipivoxil and Its Metabolite, Adefovir, in Rats.
    Yoon IS; Son JH; Kim SB; Choi MK; Maeng HJ
    Biol Pharm Bull; 2015; 38(11):1732-7. PubMed ID: 26521823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pradefovir: a prodrug that targets adefovir to the liver for the treatment of hepatitis B.
    Reddy KR; Matelich MC; Ugarkar BG; Gómez-Galeno JE; DaRe J; Ollis K; Sun Z; Craigo W; Colby TJ; Fujitaki JM; Boyer SH; van Poelje PD; Erion MD
    J Med Chem; 2008 Feb; 51(3):666-76. PubMed ID: 18173234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro, ex vivo, and in situ intestinal absorption characteristics of the antiviral ester prodrug adefovir dipivoxil.
    Annaert P; Tukker JJ; van Gelder J; Naesens L; de Clercq E; van Den Mooter G; Kinget R; Augustijns P
    J Pharm Sci; 2000 Aug; 89(8):1054-62. PubMed ID: 10906729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and food effects on the oral absorption of a poorly water soluble, highly permeable antiretroviral agent.
    Aungst BJ; Nguyen NH; Taylor NJ; Bindra DS
    J Pharm Sci; 2002 Jun; 91(6):1390-5. PubMed ID: 12115838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced dissolution and stability of adefovir dipivoxil by cocrystal formation.
    Gao Y; Zu H; Zhang J
    J Pharm Pharmacol; 2011 Apr; 63(4):483-90. PubMed ID: 21401599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid oral suspension adefovir dipivoxil (GS-02-526): an update on treatments for hepatitis B infection.
    Chen EQ; Shi Y; Wu DB; Tang H
    Expert Rev Anti Infect Ther; 2014 Aug; 12(8):919-28. PubMed ID: 24927815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism and pharmacokinetics of novel oral prodrugs of 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in dogs.
    Shaw JP; Sueoko CM; Oliyai R; Lee WA; Arimilli MN; Kim CU; Cundy KC
    Pharm Res; 1997 Dec; 14(12):1824-9. PubMed ID: 9453075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir.
    Cundy KC
    Clin Pharmacokinet; 1999 Feb; 36(2):127-43. PubMed ID: 10092959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adefovir dipivoxil in the treatment of chronic hepatitis B.
    Rivkin AM
    Ann Pharmacother; 2004 Apr; 38(4):625-33. PubMed ID: 14990784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fed and fasted state gastro-intestinal in vitro lipolysis: In vitro in vivo relations of a conventional tablet, a SNEDDS and a solidified SNEDDS.
    Christophersen PC; Christiansen ML; Holm R; Kristensen J; Jacobsen J; Abrahamsson B; Müllertz A
    Eur J Pharm Sci; 2014 Jun; 57():232-9. PubMed ID: 24056027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral bioavailability of the antiretroviral agent 9-(2-phosphonylmethoxyethyl)adenine (PMEA) from three formulations of the prodrug bis(pivaloyloxymethyl)-PMEA in fasted male cynomolgus monkeys.
    Cundy KC; Fishback JA; Shaw JP; Lee ML; Soike KF; Visor GC; Lee WA
    Pharm Res; 1994 Jun; 11(6):839-43. PubMed ID: 7937523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Safety and tolerance study of single oral dose of adefovir dipivoxil tablets in healthy volunteers].
    Wang HS; Sun DQ; Fan XP; Wang BJ; Wang K; Guo RC
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Dec; 19(4):375-9. PubMed ID: 16415999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose pharmacokinetics and safety of the oral antiviral compound adefovir dipivoxil in children infected with human immunodeficiency virus type 1. The Pediatrics AIDS Clinical Trials Group.
    Hughes WT; Shenep JL; Rodman JH; Fridland A; Willoughby R; Blanchard S; Purdue L; Coakley DF; Cundy KC; Culnane M; Zimmer B; Burchett S; Read JS
    Antimicrob Agents Chemother; 2000 Apr; 44(4):1041-6. PubMed ID: 10722509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.